The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
00
Everolimus, An Oral mTOR Inhibitor for the Treatment of Renal Angiomyolipoma Associated with TuberousSclerosis Complex or Sporadic Lymphangioleiomyomatosis: Adverse Event Management Strategies